Source: Eur Respir J 2010; 36: 1355-1361
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Hung J-J., Jeng W-J., Hsu W-H., Lin S-F., Hsieh C-C., Huang B-S., Huang M-H., Liu J-S., Chou T-Y., Wu Y-C.i. Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm. Eur Respir J 2010; 36: 1355-1361

Member's Comments

No comment yet.

Related content which might interest you: Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002 Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer Source: Eur Respir J 2013; 41: 649-655 Year: 2013 Age and stage at presentation in lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 A novel biologic classification of non-small cell lung cancer Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC) Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Staging of lung cancer Source: Eur Respir Mon; 2009: 44: 150–168 Year: 2009 TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Analysis of survival and characteristics of patients with non-small cell lung carcinoma (NSCLC) stage IV depending on molecular markers Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Factors affecting the prognosis of nonsmall cell lung cancer with chest wall-parietal pleural invasion (T3) following resection Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Treatment of early (stage I/II) non-small cell lung cancer Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment Year: 2005 Analysis of prognostic factors in patients with stage IIIB, IV non-small cell lung cancer Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006 Objective measurement of tumor central location can predict nodal involvement in patients with cT1N0M0 non-small cell lung cancer Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Analysis of risk factors for brain metastasis in locally advanced stage non-small cell carcinoma Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006 Immunohistochemical study of intratumoral micro vessels in resected non-small cell lung carcinomas, N-status, pTNM-stage and survival period of the patients Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Lung cancer Source: Respipedia Article Year: 2018 Trail receptors as prognostic factors in non-small cell lung cancer Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007